Propranolol is contraindicated in asthma

doi:10.1136/bmj.313.7070.1486

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

J M Fallowfield,
H F Marlow

Medical adviser, product safety group Senior medical adviser, clinical research group Zeneca Pharmaceuticals, Macclesfield SK10 4TG

EDITOR,—The datasheet for Inderal (propranolol) states specifically that the drug is contraindicated in patients with asthma or a history of bronchospasm. Despite this, and despite the well known risks of non-selective ß blockers in patients with asthma, over the past few years Zeneca has received a number of reports of cases in which an asthmatic patient …